Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05393869 · ClinicalTrials.gov registry record · NA

Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
2,849
Enrollment target

NCT05393869 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 2,849 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05393869, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
2,849 participants
Enrollment target

Study Summary

This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.

Interventions

  • OTHER Health communications

Trial Details

FieldValue
Enrollment Target 2,849 participants
Start Date 2021-04-14
Est. Completion 2022-11-14
Phase NA

What the Registry Record Tells You About NCT05393869

The ClinicalTrials.gov registry entry for NCT05393869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,849 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Health communications is the first listed.

NCT05393869 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05393869 about?

NCT05393869 is a clinical study titled "Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults". This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportion...

What is the current status of trial NCT05393869?

This trial is currently completed. It is a NA study. The enrollment target is 2,849 participants. The study started on 2021-04-14. Estimated completion is 2022-11-14.

What interventions are being tested in trial NCT05393869?

The interventions under investigation include: Health communications (OTHER).

Who is sponsoring clinical trial NCT05393869?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.